These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1330549)

  • 1. The delta receptor is involved in sufentanil-induced respiratory depression--opioid subreceptors mediate different effects.
    Freye E; Latasch L; Portoghese PS
    Eur J Anaesthesiol; 1992 Nov; 9(6):457-62. PubMed ID: 1330549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sufentanil-related respiratory depression and antinociception in the dog. Mediation by different receptor types.
    Latasch L; Freye E
    Arzneimittelforschung; 2002; 52(12):870-6. PubMed ID: 12572526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid receptors-mediated respiratory effects and antinociception after S(+)-ketamine.
    Latasch L; Freye E
    Acta Anaesthesiol Belg; 1993; 44(3):93-102. PubMed ID: 8310788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
    Drower EJ; Stapelfeld A; Rafferty MF; de Costa BR; Rice KC; Hammond DL
    J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid-induced respiratory depression and analgesia may be mediated by different subreceptors.
    Freye E; Schnitzler M; Schenk G
    Pharm Res; 1991 Feb; 8(2):196-9. PubMed ID: 1850827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of intravenous naltrindole and naltrindole 5'-isothiocyanate on sufentanil-induced respiratory depression and antinociception in rats.
    Verborgh C; Meert TF
    Pharmacol Biochem Behav; 1999 May; 63(1):175-83. PubMed ID: 10340539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes.
    Sofuoglu M; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1991 May; 257(2):676-80. PubMed ID: 1851833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 14-methoxymetopon, a potent opioid, induces no respiratory depression, less sedation, and less bradycardia than sufentanil in the dog.
    Freye E; Schmidhammer H; Latasch L
    Anesth Analg; 2000 Jun; 90(6):1359-64. PubMed ID: 10825321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between opioid antagonists and amphetamine: evidence for mediation by central delta opioid receptors.
    Jones DN; Holtzman SG
    J Pharmacol Exp Ther; 1992 Aug; 262(2):638-45. PubMed ID: 1323656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB).
    Malmberg AB; Yaksh TL
    J Pharmacol Exp Ther; 1992 Oct; 263(1):264-75. PubMed ID: 1328610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interaction of S-(+)-ketamine with opiate receptors. Effects on EEG, evoked potentials and respiration in awake dogs].
    Freye E; Latasch L; Schmidhammer H; Portoghese P
    Anaesthesist; 1994 Nov; 43 Suppl 2():S52-8. PubMed ID: 7840415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta opiate receptors mediate tail-shock induced antinociception at supraspinal levels.
    Watkins LR; Wiertelak EP; Maier SF
    Brain Res; 1992 Jun; 582(1):10-21. PubMed ID: 1323369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist and antagonist activities of ligands derived from naltrexone and oxymorphone.
    Takemori AE; Sultana M; Nagase H; Portoghese PS
    Life Sci; 1992; 50(20):1491-5. PubMed ID: 1315896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid-induced stimulation of fetal respiratory activity by [D-Ala2]deltorphin I.
    Cheng PY; Wu D; Decena J; Soong Y; McCabe S; Szeto HH
    Eur J Pharmacol; 1993 Jan; 230(1):85-8. PubMed ID: 8381356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociception after intracerebroventricular administration of naltrindole in the mouse.
    Stapelfeld A; Hammond DL; Rafferty MF
    Eur J Pharmacol; 1992 Apr; 214(2-3):273-6. PubMed ID: 1325358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta opioid receptor selective alkaloid agonists and antagonists.
    Woods JH; DeCosta B; Jacobson AE; Rice KC; Medzihradsky F; Smith CB; Comer S; France CP; Winger G
    NIDA Res Monogr; 1989; 95():300-1. PubMed ID: 2561836
    [No Abstract]   [Full Text] [Related]  

  • 17. Antagonism of swim-stress-induced antinociception by the delta-opioid receptor antagonist naltrindole in adult and young rats.
    Kitchen I; Pinker SR
    Br J Pharmacol; 1990 Aug; 100(4):685-8. PubMed ID: 2169936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of spacer and address components in peptidomimetic delta opioid receptor antagonists related to naltrindole.
    Portoghese PS; Nagase H; MaloneyHuss KE; Lin CE; Takemori AE
    J Med Chem; 1991 May; 34(5):1715-20. PubMed ID: 1851846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kappa opiate receptors mediate tail-shock induced antinociception at spinal levels.
    Watkins LR; Wiertelak EP; Maier SF
    Brain Res; 1992 Jun; 582(1):1-9. PubMed ID: 1354010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lack of potency for the delta-opioid antagonist naltrindole after microinjection into the rostral ventrolateral medulla of rabbits.
    Morilak D; Drolet G; Chalmers J
    Clin Exp Pharmacol Physiol; 1990 Jul; 17(7):527-30. PubMed ID: 2169364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.